When it comes to health, bigger is not necessarily better. The term "morbid obesity" has become common vernacular in recent years, even outside of clinics and hospitals. But can bigger mean better when it comes to finding the best approach to managing DM? Two schools of thought preside in the health plan market today: Compile a stable of disease-specific vendors and coordinate them in-house (also referred to as "best-of-breeders"), or choose a single vendor to handle all the disease management programs.
When it comes to health, bigger is not necessarily better. The term "morbid obesity" has become common vernacular in recent years, even outside of clinics and hospitals. But can bigger mean better when it comes to finding the best approach to managing DM? Two schools of thought preside in the health plan market today: Compile a stable of disease-specific vendors and coordinate them in-house (also referred to as "best-of-breeders"), or choose a single vendor to handle all the disease management programs.
Mike Norris, assistant vice president of medical outreach for Denver-based Great-West Healthcare, believes that this is the best available option, in spite of the trend toward single-source solutions. "Of greatest concern for us is the quality of the clinical health outcomes we provide for our members," he says. "While reviewing and choosing multiple vendors can be a time-consuming and difficult process, the clinical quality of the program is always going to be the determining factor for us."
"Just as PCPs look at their members holistically, we try to see our members in the same light," he says. "Conditions such as asthma or chronic obstructive pulmonary disease (COPD) are really just a starting point...utilization and morbidity usually are driven by clusters of comorbid conditions, not just one. Our integrated approach, which we refer to as complex case management, reflects that belief."
That makes IT fragmentation one of the most important issues that healthcare payers need to address. There might not be a right or wrong answer to the "single-source vs. best-of-breed" debate, but an increasing number of experts lean toward the integrated approach, including Al Lewis, founder of the Disease Management Purchasing Consortium and a member of MHE's Editorial Advisory Board, and Jennifer Gaudet, a healthcare analyst with Forrester Research Inc.
According to Gaudet's report, plans that effectively implement an IHM strategy will be rewarded with:
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
Mental Health Comorbidities Affect Uptravi Prescribing for PAH
October 23rd 2024New real-world data suggest that physicians are cautious about prescribing the prostacyclin-receptor agonist Uptravi (selexipag) to pulmonary arterial hypertension (PAH) patients with mental health conditions when evidence suggests that it is best to take a proactive approach to treating PAH.
Read More